Acquired by SPARC MA in August 2018 as part of Dr. Moran’s CFI-IF award, the innovative Tribrid architecture of the Orbitrap FusionTM LumosTM mass spectrometer enables unprecedented gains in biological system characterization. Equipped with ETD and UVPD fragmentation modes, it is our most selective and versatile instrument. The Lumos can analyze the most challenging, low-abundance, high-complexity samples and is also engineered to handle heavier protein fragments.
top of page
Announcements
Search
Recent Posts
See AllThe McGill node will receive funding for the next 3 years from FACS (Fonds d'accélération des collaborations en santé)
10
The McGill node is proud to be part of the newly established Montreal Cancer Consortium (MCC) funded by the Terry Fox Foundation
3
bottom of page
Commentaires